Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2026-02-27 @ 8:28 AM
Study NCT ID:
NCT00616005
Status:
COMPLETED
Last Update Posted:
2014-08-18
First Post:
2008-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00012939
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |